Here is the full story (Avg mod buy C$7.47) WELL Health Technologies (TSE:WELL - Get Free Report) was downgraded by research analysts at CIBC from an "outperform" rating to a "neutral" rating in a research report issued on Monday, BayStreet.CA reports. They currently have a C$4.75 target price on the stock, down from their previous target price of C$5.50. CIBC's price objective would indicate a potential upside of 26.33% from the stock's previous close.
Several other research firms also recently weighed in on WELL. Laurentian cut their price target on WELL Health Technologies from C$9.00 to C$6.50 and set a "buy" rating for the company in a research note on Thursday, November 16th. Desjardins dropped their price target on WELL Health Technologies from C$5.50 to C$5.25 and set a "hold" rating for the company in a research report on Wednesday, November 15th. TD Securities dropped their price target on WELL Health Technologies from C$8.50 to C$8.00 and set a "buy" rating for the company in a research report on Wednesday, November 15th. Finally, Stifel Nicolaus dropped their price target on WELL Health Technologies from C$12.00 to C$11.00 and set a "buy" rating for the company in a research report on Wednesday, November 15th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of C$7.47.